Sept 8: At the end of July, Citius Pharmaceuticals received a Complete Response Letter from the FDA pertaining to its Biologics License Application for Lymphir, an engineered IL-2-diphtheria toxin fusion protein intended to treat relapsed or refractory cutaneous T-cell lymphoma
When Oral Supplements Are Sufficient: Mild Deficiency Cases: Dietary insufficiency without absorption issues Preventive supplementation Cost-conscious approach No underlying digestive problems Recommended Dosage: 250-1000 mcg daily for maintenance When B12 Injections Are Superior: Severe Deficiency or Absorption Issues: Pernicious anemia Digestive disorders affecting absorption Rapid correction needed Previous failed oral supplementation The Science: Intramuscular B12 injections bypass the digestive system entirely, providing 100% bioavailability compared to 1-5% from oral supplements in deficient individuals
For example, methylation of HIN1, TFPI2, DACH1, and SOX17 (Ma et al., 2016) has shown promising results
At the core of neutrophil polarization lies the dynamic remodeling of cytoskeletal proteins
It has a well-documented role in tissue repair, collagen synthesis, and angiogenesis, and topical formulations are widely marketed for androgenetic alopecia